List of articles with "Obesity Treatment"

MetaVia Phase 1 Trial

MetaVia Phase 1 Trial

United States Cambridge MetaVia Obesity Treatment DA-1726
RESET® Device CE Mark Success

RESET® Device CE Mark Success

USA Boston Obesity Treatment Morphic Medical RESET®
Low GLP-1 Drug Persistence

Low GLP-1 Drug Persistence

USA GLP-1 Eagan Obesity Treatment Prime Therapeutics
FDA Approval for EndoZip™

FDA Approval for EndoZip™

USA Caesarea Obesity Treatment Nitinotes EndoZip™
Obesity Treatment Update

Obesity Treatment Update

United States Obesity Treatment Belmont Supercede Therapeutics SPCD-4-79
GLP-1 Medications Breakthrough

GLP-1 Medications Breakthrough

USA Chicago Obesity Treatment GLP-1 Medications Type 2 Diabetes
Promising Results of MariTide

Promising Results of MariTide

United States California MariTide Amgen Obesity Treatment
Novo Nordisk Amycretin

Novo Nordisk Amycretin

United States Novo Nordisk Plainsboro Obesity Treatment amycretin
ADA Scientific Sessions

ADA Scientific Sessions

Obesity Treatment American Diabetes Association diabetes research
Rise in GLP-1 Usage

Rise in GLP-1 Usage

United States New York FAIR Health Obesity Treatment GLP-1 drugs
EndoZip™ Clinical Results

EndoZip™ Clinical Results

Israel Caesarea Obesity Treatment EndoZip Nitinotes
Ousia Pharma Funding

Ousia Pharma Funding

USA Boston Obesity Treatment Ousia Pharma Omega Funds
Ousia's Seed Financing

Ousia's Seed Financing

USA Boston Obesity Treatment Ousia Pharma Omega Funds
MetaVia DA-1726 Results

MetaVia DA-1726 Results

USA Cambridge MetaVia Obesity Treatment DA-1726
DA-1726 Clinical Trial Insights

DA-1726 Clinical Trial Insights

USA Cambridge MetaVia Obesity Treatment DA-1726
Gender Divide in Obesity Drugs

Gender Divide in Obesity Drugs

USA San Francisco Obesity Treatment Olio Labs GLP-1 drugs
Ascletis ASC47 Phase Ib Results

Ascletis ASC47 Phase Ib Results

USA Hong Kong ASC47 Obesity Treatment Ascletis Pharma
Hoth's GDNF Breakthrough

Hoth's GDNF Breakthrough

USA New York Hoth Therapeutics Obesity Treatment GDNF
Ascletis Phase Ib Results

Ascletis Phase Ib Results

USA Hong Kong Obesity Treatment ASC30 Ascletis Pharma
Innovative Patent for Obesity

Innovative Patent for Obesity

United States Huntington Obesity Treatment Sen-Jam Pharmaceutical metabolic disorders
Halia's Upcoming Events

Halia's Upcoming Events

USA San Francisco Healthcare Conference Halia Therapeutics Obesity Treatment
VK2735 Phase 2 Trial

VK2735 Phase 2 Trial

United States San Diego Viking Therapeutics Obesity Treatment VK2735
Hoth and VA Team Up

Hoth and VA Team Up

USA New York Hoth Therapeutics VA Department Obesity Treatment

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.